SA

Saiprasad Anjaneyagowda

Director DIN 02053754
DIN 02053754 First appointment Oct 2007
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Saiprasad Anjaneyagowda

Data last updated:

Saiprasad Anjaneyagowda was a Director at Afd Laboratories Private Limited (from 2007) and Director at Afd Pharma Private Limited (from 2010).

DIN 02053754
First Appointment 01 Oct 2007
Oldest Company Age 45 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Afd Laboratories Private Limited U24231MH1981PTC208301
Director01 Oct 20071981₹1.53 Cr (FY 2023)Amalgamated
Afd Pharma Private Limited U24231MH1995PTC208147
Director30 Jan 20101995₹40,756 (FY 2022)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Afd Laboratories Private Limited
Afd Pharma Private Limited
Premium access

Shareholding and investment profile for Saiprasad Anjaneyagowda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saiprasad Anjaneyagowda

Saiprasad Anjaneyagowda was first appointed on 01 Oct 2007 as Director at Afd Laboratories Private Limited. The most recent appointment on record is 30 Jan 2010 at Afd Pharma Private Limited.

Saiprasad Anjaneyagowda held 2 earlier board appointments: Afd Laboratories Private Limited (Director, from 01 Oct 2007); Afd Pharma Private Limited (Director, from 30 Jan 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available